News Amgen hands off leprosy, TB candidate to Australian non-prof... Amgen has decided that a drug for leprosy and tuberculosis it inherited as part of its acquisition of Celgene’s psoriasis blockbuster
News AstraZeneca reportedly hit by serious cyberattack A hacking group claims to have broken into AstraZeneca's IT systems and stolen confidential data, which they are now offering for sale.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.